Skip to Content

Sorafenib

In the US, Sorafenib (sorafenib systemic) is a member of the following drug classes: multikinase inhibitors, VEGF/VEGFR inhibitors and is used to treat Hepatic Tumor, Hepatocellular Carcinoma, Renal Cell Carcinoma and Thyroid Cancer.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XE05

CAS registry number (Chemical Abstracts Service)

0284461-73-0

Chemical Formula

C21-H16-Cl-F3-N4-O3

Molecular Weight

464

Therapeutic Categories

Cytostatic agent

Angiogenesis inhibitor

Tyrosine kinase inhibitor

Chemical Names

4-(4-{3-[4-Chloro-3-(trifluorometyl)phenyl]ureido}phenoxy)-N²-metylpyridine-2-carboxamide (WHO)

4-{4-[3-(4-Chlor-3-trifluormetylphenyl)ureido]phenoxy}pyridin-2-carbonsäuremetylamid (IUPAC)

Foreign Names

  • Sorafenibum (Latin)
  • Sorafenib (German)
  • Sorafénib (French)
  • Sorafenib (Spanish)

Generic Names

Brand Names

  • Nexavar
    Bayer, Bosnia & Herzegowina; Bayer, China; Bayer, Egypt; Bayer, Hong Kong; Bayer, Lebanon; Bayer, Turkey; Bayer HealthCare, Singapore; Bayer Schering, Taiwan; Bayer Thai Co Ltd, Thailand; Bayer, Belgium; Bayer, Canada; Bayer, Chile; Bayer, Colombia; Bayer, Denmark; Bayer, Ecuador; Bayer, Spain; Bayer, United Kingdom; Bayer, Greece; Bayer, Croatia (Hrvatska); Bayer, Hungary; Bayer, Ireland; Bayer, Italy; Bayer, Latvia; Bayer, Netherlands; Bayer, New Zealand; Bayer, Oman; Bayer, Philippines; Bayer, Poland; Bayer, Portugal; Bayer, Romania; Bayer, Sweden; Bayer, Slovakia; Bayer Health Care, Malaysia; Bayer HealthCare, Finland; Bayer HealthCare, Russian Federation; Bayer HealthCare, United States; Bayer Pharma, Austria; Bayer Pharma AG, Norway; Bayer Santé, France; Bayer Schering, Australia; Bayer Schering, Czech Republic; Bayer Schering, Lithuania; Bayer Schering, Serbia; Bayer Schering, South Africa; Bayer Vital, Germany; Bayer Yakuhin, Japan; Bayer-Schering, Iceland; Emra-Med Arzneimittel, Austria; Eurim-Pharm, Austria; Haemato Pharm, Austria; Orifarm, Norway

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide